MED12 exon 2 mutations are common in uterine leiomyomas from South African patients
Citations Over TimeTop 10% of 2011 papers
Abstract
Uterine leiomyomas, or fibroids, are extremely common tumors. Regardless of their benign nature, fibroids can cause considerable morbidity. Women with African ancestry have a threefold increased risk of developing uterine leiomyomas with a greater symptom severity when compared to white women. Recently, we demonstrated that exon 2 of the MED12 gene is somatically altered in up to 70 per cent of uterine leiomyomas in a series of Finnish (Caucasian) patients. To validate these results in other populations, we sequenced a set of 28 uterine leiomyomas for MED12 exon 2 mutations from 18 different Black African or Coloured South African patients. We observed 14 mutation positive lesions (50%). When corrected by tumor size, these results are very similar to those derived in the Finnish material. This study confirms a major role of MED12 in the genesis of leiomyomas, regardless of ethnicity.
Related Papers
- → Clinical predictors in the natural history of uterine leiomyoma: preliminary study.(1998)47 cited
- → 18F-Fluorodeoxyglucose uptake in uterine leiomyomas in healthy women(2009)6 cited
- → Predicting the Effect of Gonadotropin-Releasing Hormone (GnRH) Analogue Treatment on Uterine Leiomyomas Based on MR Imaging(1999)10 cited
- → Association of breakpoint 14q23 with uterine leiomyoma(1988)27 cited
- Change and significance of IGFBP-3 in serum and leiomyoma tissue of patients with uterine leiomyoma(2009)